Jeong et al51 demonstrated that estrogen receptor (ER) and progesterone receptor (PR) expression in breast carcinoma tissues was notably related to the expression of LOXL3, and LOXL3 expression had no relationship with the outcomes of breast carcinoma patients. This evidence concerns the gene LOXL3 and breast carcinoma.